Background: Direct-to-consumer advertising (DTCA), linked to inappropriate medication use
and higher health care expenditures, is the fastest growing form of pharmaceutical …

The Oxford Handbook of Health Economics provides an accessible and authoritative guide
to health economics, intended for scholars and students in the field, as well as those in …

This review discusses the role of consumer-directed and physician-directed promotion in the
pharmaceutical market, based on the classic conceptual framework of whether such …

Context: One of the serious global problems is the irrational prescribing of medicines that
can be regarded as harmful or wasteful. Inappropriate use and overuse of medicines, waste …

Our paper is a first attempt to evaluate the long run impact of reference pricing on
pharmaceutical innovation, health and expenditures. The model is based on a dynamic …

Prescription drug expenditures are the fastest growing component of health care spending,
rising threefold over the 1995–2007 period. Coinciding with this growth has been a surge in …

We investigate the effect of competition on quality in health care markets with regulated
prices taking a differential game approach, in which quality is a stock variable. Using a …

Generic drugs are sold at a fraction of the original brand price. Yet, generic entry typically
produces a drop in the quantity market share of the molecule losing exclusivity. This effect is …

This chapter covers the application of concepts and tools of the theory of asymmetric
information (AI) to the realm of health economics. As Arrow already pointed out in 1963 …

We study incentives for quality provision in markets where providers are motivated (semi-
altruistic); prices are regulated and firms are funded by a combination of block grants and …